Literature DB >> 14140852

PROPHYLACTIC ENDOCRINE TREATMENT IN CARCINOMA OF THE BREAST.

R NISSEN-MEYER.   

Abstract

Entities:  

Keywords:  ANDROGENS; BREAST NEOPLASMS; CASTRATION; CORTISONE; ESTROGENS; MASTECTOMY; MENOPAUSE; NANDROLONE; NEOPLASM METASTASIS; NEOPLASM RADIOTHERAPY; NEOPLASM STATISTICS; NEOPLASM THERAPY; OVARY; PALLIATIVE TREATMENT; PREDNISONE; PROGESTERONE; TESTOSTERONE

Mesh：

Substances：

Year:  1964        PMID： 14140852     DOI： 10.1016/s0009-9260(64)80031-3

Source DB:  PubMed          Journal:  Clin Radiol        ISSN： 0009-9260            Impact factor:   2.350


× No keyword cloud information.
  5 in total

1.  Value of prophylactic oophorectomy in advanced breast cancer with parasternal lymph nodes metastasis.

Authors:  M Jimi; M Katano; H Kishikawa
Journal:  Jpn J Surg       Date:  1977-06

Review 2.  Current status of the management of patients with endocrine-sensitive tumors. I. Introduction and carcinoma of the breast.

Authors:  L G Crowley
Journal:  Calif Med       Date:  1969-01

3.  Ovarian irradiation and prednisone therapy following surgery and radiotherapy for carcinoma of the breast.

Authors:  J W Meakin; W E Allt; F A Beale; T C Brown; R S Bush; R M Clark; P J Fitzpatrick; N V Hawkins; R D Jenkin; J F Pringle; J G Reid; W D Rider; J L Hayward; R D Bulbrook
Journal:  Can Med Assoc J       Date:  1979-05-19       Impact factor: 8.262

4.  Serum oestrogen receptor alpha and beta bioactivity are independently associated with breast cancer: a proof of principle study.

Authors:  M Widschwendter; H Lichtenberg-Frate; G Hasenbrink; S Schwarzer; A Dawnay; A Lam; U Menon; S Apostolidou; E Raum; C Stegmaier; I J Jacobs; H Brenner
Journal:  Br J Cancer       Date:  2009-06-02       Impact factor: 7.640

5.  Prognostic effect of preoperative serum estradiol level in postmenopausal breast cancer.

Authors:  Ju-Yeon Kim; Wonshik Han; Hyeong-Gon Moon; Soo Kyung Ahn; Jisun Kim; Jun Woo Lee; Min Kyoon Kim; Taeryung Kim; Dong-Young Noh
Journal:  BMC Cancer       Date:  2013-10-27       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.